18-6-2-2　ⓔ文献

  1. Steele JC, Richardson JC, et al: Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol, 1964; 10: 333–359.

  2. Takigawa H, Kitayama M, et al: Prevalence of progressive supranuclear palsy in Yonago: change throughout a decade. Brain Brhave, 2016; 6: e00557.

  3. Albert ML, Feldman RG, et al: The ‘subcortical dementia’ of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry, 1974; 37: 121–130.

  4. Litvan I, Agid Y, et al: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS─SPSP international workshop. Neurology, 1996; 47: 1–9.

  5. Höglinger GU, Respondek G, et al: Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord, 2017; 32: 853–864.

  6. Ali F, Martin PR, et al: Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy. Mov Disord, 2019; 34: 1144–1153.

  7. Williams DR, de Silva R, et al: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP–parkinsonism. Brain, 2005; 128: 1247–1258.

  8. 中山英己，小西高志，他：易転倒性に対し少量のtrihexyphenidylが著効した進行性核上性麻痺例．神経内科，2002; 56: 248–250.